Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis

Source:
NHS Economic Evaluation Database - NHS EED
Publication date:
09 August 2008

Abstract

Bibliographic details

Oxlade O, Schwartzman K, Menzies D.  Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. International Journal of Tuberculosis and Lung Disease 2007; 11(1): 16-26

Status

This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.

CRD summary

Indexing status

Subject indexing assigned by NLM

Index terms

Biological Markers /blood; Canada /epidemiology; Cost-Benefit Analysis; Developed Countries; Emigration and Immigration; Humans; Incidence; Income; Interferon-gamma /blood; Markov Chains; Mass Screening /economics /methods; Radiography, Thoracic /economics; Sensitivity and Specificity; Tuberculin Test; Tuberculosis /blood /diagnosis /economics /epidemiology